Seroprevalence of human papillomavirus type 16 infection in the United States
- PMID: 12404154
- DOI: 10.1086/344354
Seroprevalence of human papillomavirus type 16 infection in the United States
Abstract
Infection with human papillomavirus (HPV) type 16 accounts for about half of cervical cancers worldwide. This study investigated the seroepidemiology of HPV-16 infection in the United States by using a population-based survey. Serum samples and questionnaire data were collected from 1991 to 1994 for the National Health and Nutrition Examination Surveys. HPV-16-specific IgG antibody was detected by use of an HPV-16 virus-like particle ELISA. HPV-16 seropositivity in the US population aged 12-59 years was 13.0% (95% confidence interval, 11.5%-14.7%). Seroprevalence was higher in women (17.9%) than in men (7.9%). Age, race/ethnicity, and number of lifetime sex partners were associated with HPV seropositivity in women. Race/ethnicity, age at first intercourse, urban/nonurban residence, years of sexual activity, and having had sex with a man were associated with HPV seropositivity in men. Information on HPV-16 seroepidemiology will be important for designing prevention efforts including vaccine programs.
Comment in
-
Modification of sexual behaviors is important for the prevention of human papillomavirus infection.J Infect Dis. 2003 Jul 1;188(1):177. doi: 10.1086/375745. J Infect Dis. 2003. PMID: 12825191 No abstract available.
Similar articles
-
Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994.Sex Transm Dis. 2008 Mar;35(3):298-303. doi: 10.1097/OLQ.0b013e31815abaef. Sex Transm Dis. 2008. PMID: 18091027
-
Seroprevalence of human papillomavirus type 16 in children.J Infect Dis. 2005 Jun 1;191(11):1817-9. doi: 10.1086/430274. Epub 2005 May 2. J Infect Dis. 2005. PMID: 15871113
-
Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1129-36. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11700260
-
Human papillomavirus infection: epidemiology and pathophysiology.Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S2-5. doi: 10.1016/j.ygyno.2007.07.067. Gynecol Oncol. 2007. PMID: 17938014 Review.
-
Recurrent respiratory papillomatosis.J La State Med Soc. 1998 Oct;150(10):456-9. J La State Med Soc. 1998. PMID: 9805867 Review.
Cited by
-
Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men.J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):479-87. doi: 10.1097/QAI.0b013e3182a7acd2. J Acquir Immune Defic Syndr. 2013. PMID: 24231786 Free PMC article.
-
Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study.J Infect Dis. 2011 Jan 1;203(1):49-57. doi: 10.1093/infdis/jiq021. J Infect Dis. 2011. PMID: 21148496 Free PMC article.
-
An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies.Cancer Causes Control. 2011 Sep;22(9):1217-31. doi: 10.1007/s10552-011-9792-x. Epub 2011 Jul 9. Cancer Causes Control. 2011. PMID: 21744095 Free PMC article.
-
Associations between human papillomavirus and history of cancer among U.S. adults in the National Health and Nutrition Examination Survey (2003-2010).Br J Cancer. 2014 Sep 23;111(7):1448-53. doi: 10.1038/bjc.2014.414. Epub 2014 Jul 24. Br J Cancer. 2014. PMID: 25058348 Free PMC article.
-
Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.PLoS One. 2012;7(11):e48807. doi: 10.1371/journal.pone.0048807. Epub 2012 Nov 12. PLoS One. 2012. PMID: 23152809 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
